Revvity Long Term Debt 2010-2024 | RVTY

Revvity long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Revvity long term debt for the quarter ending September 30, 2024 was $3.163B, a 18.57% decline year-over-year.
  • Revvity long term debt for 2023 was $3.178B, a 19% decline from 2022.
  • Revvity long term debt for 2022 was $3.923B, a 21.21% decline from 2021.
  • Revvity long term debt for 2021 was $4.98B, a 209.36% increase from 2020.
Revvity Annual Long Term Debt
(Millions of US $)
2023 $3,178
2022 $3,923
2021 $4,980
2020 $1,610
2019 $2,064
2018 $1,877
2017 $1,789
2016 $1,045
2015 $1,012
2014 $1,045
2013 $932
2012 $939
2011 $945
2010 $424
2009 $558
Revvity Quarterly Long Term Debt
(Millions of US $)
2024-06-30 $3,163
2024-03-31 $3,165
2023-12-31 $3,178
2023-09-30 $3,152
2023-06-30 $3,884
2023-03-31 $3,881
2022-12-31 $3,923
2022-09-30 $3,898
2022-06-30 $4,484
2022-03-31 $4,864
2021-12-31 $4,980
2021-09-30 $5,099
2021-06-30 $2,349
2021-03-31 $2,220
2020-12-31 $1,610
2020-09-30 $1,493
2020-06-30 $1,625
2020-03-31 $2,011
2019-12-31 $2,064
2019-09-30 $1,751
2019-06-30 $2,104
2019-03-31 $1,849
2018-12-31 $1,877
2018-09-30 $1,883
2018-06-30 $1,984
2018-03-31 $1,860
2017-12-31 $1,789
2017-09-30 $1,109
2017-06-30 $1,089
2017-03-31 $1,053
2016-12-31 $1,045
2016-09-30 $1,132
2016-06-30 $1,057
2016-03-31 $1,120
2015-12-31 $1,012
2015-09-30 $1,027
2015-06-30 $986
2015-03-31 $1,015
2014-12-31 $1,045
2014-09-30 $859
2014-06-30 $894
2014-03-31 $927
2013-12-31 $932
2013-09-30 $933
2013-06-30 $1,002
2013-03-31 $1,019
2012-12-31 $939
2012-09-30 $931
2012-06-30 $911
2012-03-31 $934
2011-12-31 $945
2011-09-30 $150
2011-06-30 $671
2011-03-31 $514
2010-12-31 $424
2010-09-30 $670
2010-06-30 $620
2010-03-31 $528
2009-12-31 $558
2009-09-30 $577
2009-06-30 $524
2009-03-31 $544
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00